- US12606541utility2026Pparg Modulators and Methods of Use0 cites
- US12564641utility2026Eribulin Antibody-drug Conjugates and Methods of Use0 cites
- US12564600utility2026System for Enhancing Therapeutic Compliance of the Anti-cancer Compound E77660 cites
- US12545675utility2026Anti-wolbachia Pyrido[2,3-d]pyrimidine Compounds0 cites
- US12545894utility2026Method for Inducing Dopaminergic Neuron Progenitor Cells0 cites
- US12508313utility2025Quinoline Derivative-containing Pharmaceutical Composition0 cites
- US12504431utility2025Biomarkers for a Therapy Comprising a Sorafenib Compound0 cites
- US12479819utility2025Method and Compound Useful in Preparation of Orexin-2 Receptor Antagonist, and Lemborexant Having Few Impurities0 cites
- US12447173utility2025Pharmaceutical Composition Containing Double-stranded Ribonucleic Acid Inhibiting Expression of Complement C50 cites
- US12421246utility2025Method for Synthesis of Diazabicyclo[6.2.0]decane Related Compounds0 cites
- US12421248utility2025Macrocyclic Compound and Uses Thereof0 cites
- US12414945utility2025Therapeutic Agent for Breast Cancer0 cites
- US12384824utility2025Method for Producing an Active Hepatocyte Growth Factor (HGF)0 cites
- US12364690utility2025Therapeutic Agent for Bile Duct Cancer0 cites
- US12303505utility2025Tumor-treating Pharmaceutical Composition0 cites
- US12303499utility2025Aqueous Based Pharmaceutical Formulations of 1,2-dihydropyridine Compounds0 cites
- US12251386utility2025Salt Form of a Human Histone Methyltransferase EZH2 Inhibitor0 cites
- US12251394utility2025Methods for the Treatment of Bladder Cancer0 cites
- USD1066682design2025Charging Unit for a Health Condition Monitoring System0 cites
- US12226409utility2025Treatment of Hepatocellular Carcinoma0 cites
Page 1 of 3Next →